COGT
Cogent Biosciences
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
COGT Profile
Cogent Biosciences, Inc.
A biotechnology company that focused on developing novel precision immunotherapies to treat cancer
275 Wyman Street, 3rd Floor, Waltham, Massachusetts 02451
--
Cogent Biosciences, Inc., was founded in Delaware. The company is a biotechnology company that develops precision therapies for genetic diseases. Cogent's most advanced product, PLX 9486, is a highly selective tyrosine kinase inhibitor designed to effectively inhibit KIT D816V mutations and other mutations in KIT exon 17. KITD816V can cause a rare and serious disease called systemic mastocytosis.